FOXA1 Is Required for Urothelial Differentiation and Its Loss in Bladder Cancer Is Associated With Poor Prognosis

被引：0
|
作者：
Reddy, Opal
Cates, Justin
Gellert, Lan
Crist, Henry
Yang, Zhaohai
Taylor, John
Smith, Joseph
Chang, Sam
Cookson, Michael
You, Chaochen
Barocas, Daniel
Grabowska, Magdalena
Ye, Fei
Wu, Xue-Ru
Matusik, Robert
Kaestner, Klaus
Clark, Peter
DeGraff, David
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Vanderbilt Univ, Nashville, TN 37235 USA
[3] Penn State Univ, Hershey, PA USA
[4] Univ Connecticut, Farmington, CT USA
[5] Univ Oklahoma, Oklahoma City, OK USA
[6] NYU, New York, NY USA
[7] Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1008
引用
收藏
页码：253A / 253A
页数：1
相关论文
共 50 条
  • [21] Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis
    Zhao, Guobin
    Wang, Chao
    Tang, Yuhong
    Liu, Xin
    Liu, Zihao
    Li, Gang
    Mei, Yanhui
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] FOXA1 a Poor Prognostic Marker in Prostate Cancer: A Validation Study
    Jain, R. K.
    Mehta, R.
    Ro, J.
    Nakshatri, H.
    Cho, Y. M.
    Badve, S.
    MODERN PATHOLOGY, 2011, 24 : 200A - 200A
  • [23] FOXA1 a Poor Prognostic Marker in Prostate Cancer: A Validation Study
    Jain, R. K.
    Mehta, R.
    Ro, J.
    Nakshatri, H.
    Cho, Y. M.
    Badve, S.
    LABORATORY INVESTIGATION, 2011, 91 : 200A - 200A
  • [24] INACTIVATION OF FOXA1 COOPERATES WITH PTEN COPY NUMBER LOSS IN BLADDER CANCER TO PROMOTE TUMOR HETEROGENEITY
    Shuman, Lauren
    Osei-Amponsa, Vasty
    Buckwalter, Jenna
    Zheng, Zongyu
    Yamashita, Hironobu
    Walter, Vonn
    Ellis, Justine
    Lu, Chang
    Warrick, Joshua
    Shantz, Lisa
    Feehan, Robert
    Al-Ahmadie, Hikmat
    Mendelsohn, Cathy
    Kaestner, Klaus
    Wu, Xue-Ru
    DeGraff, David
    JOURNAL OF UROLOGY, 2019, 201 (04): : E727 - E728
  • [25] Time-varying effects of FOXA1 on breast cancer prognosis
    Chen, Qian-xin
    Yang, Yuan-zhong
    Liang, Zhuo-zhi
    Chen, Jia-li
    Li, Yue-lin
    Huang, Zi-yi
    Weng, Zi-jin
    Zhang, Xiao-fang
    Guan, Jie-xia
    Tang, Lu-ying
    Yun, Jing-ping
    Ren, Ze-fang
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (03) : 867 - 875
  • [26] Time-varying effects of FOXA1 on breast cancer prognosis
    Qian-xin Chen
    Yuan-zhong Yang
    Zhuo-zhi Liang
    Jia-li Chen
    Yue-lin Li
    Zi-yi Huang
    Zi-jin Weng
    Xiao-fang Zhang
    Jie-xia Guan
    Lu-ying Tang
    Jing-ping Yun
    Ze-fang Ren
    Breast Cancer Research and Treatment, 2021, 187 : 867 - 875
  • [27] IDENTIFICATION OF FOXA1 AS A MASTER REGULATOR OF PPARγ ACTION IN BLADDER CANCER
    Buckwalter, Jenna
    Groeneveld, Clarice
    Tang, Priscilla
    Yamashita, Hiro
    Robertson, A. Gordon
    Castro, Mauro
    DeGraff, David
    JOURNAL OF UROLOGY, 2020, 203 : E230 - E231
  • [28] FOXA1 KNOCKOUT IS ASSOCIATED WITH INCREASED CARCINOGENIC SUSCEPTIBILITY AND ANDROGEN RECEPTOR EXPRESSION IN MURINE BLADDER CANCER
    Shuman, Lauren
    Zheng, Zongyu
    Yamashita, Hironobu
    Warrick, Joshua
    Kaestner, Klaus
    DeGraff, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1316 - E1316
  • [29] MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer
    Drayton, Ross M.
    Peter, Stefan
    Myers, Katie
    Miah, Saiful
    Dudziec, Ewa
    Bryant, Helen E.
    Catto, James W. F.
    ONCOTARGET, 2014, 5 (15) : 6375 - 6386
  • [30] FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
    Adams, Elizabeth J.
    Karthaus, Wouter R.
    Hoover, Elizabeth
    Liu, Deli
    Gruet, Antoine
    Zhang, Zeda
    Cho, Hyunwoo
    DiLoreto, Rose
    Chhangawala, Sagar
    Liu, Yang
    Watson, Philip A.
    Davicioni, Elai
    Sboner, Andrea
    Barbieri, Christopher E.
    Bose, Rohit
    Leslie, Christina S.
    Sawyers, Charles L.
    NATURE, 2019, 571 (7765) : 408 - +
12345